Article summary
We have tracked every investment for the past ten years. Each year, we provide a review of the previous year’s psychedelics fundraising activity, public markets, and M&A. Here, we explore Q4 and full year 2025 via data visualisation and commentary.
Continue to the original publication for the complete article.